FOR IMMEDIATE RELEASE FROM MARY ANN LIEBERT, INC., PUBLISHERS New Rochelle, NY, January 8, 2025 A new study found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased risk of thyroid cancer
The issue lies not only in the facial volume loss, but in the rate of that loss, said Chau Pham, MD, FACS
Electron microscopic immunocytochemistry (immunogold labeling) of pheochromocytoma cells demonstrated DSIP-LI over the dense core of secretory granules
It is crucial to consider these differences and speak with a healthcare professional, such as the Infinite Wellness Hormone Specialist in Scottsdale, AZ, to determine the best choice for individual health goals
But since Ozempic contains the identical active ingredient and produces similar results, many doctors prescribe it off-label for weight management